Published in Br J Cancer Suppl on June 01, 1978
Radiosensitizers of hypoxic cells in solid tumors. Cancer Treat Rev (1976) 2.33
A lung-colony assay to determine the radiosensitivity of cells of a solid tumour. Int J Radiat Biol Relat Stud Phys Chem Med (1969) 2.27
In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique. Br J Radiol (1975) 1.86
The effect on cell survival of inhalation of oxygen under high pressure during irradiation in vivo of a solid mouse sarcoma. Br J Radiol (1966) 1.81
The effects of nitrobenzene derivatives on oxygen utilization and radiation response of an in vitro tumor model. Radiat Res (1976) 1.45
HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION. Biochem Biophys Res Commun (1963) 1.23
Nitrofurans as radiosensitizers of hypoxic mammalian cells. Cancer Res (1972) 1.19
Electron affinic sensitization. II. Para-nitroacetophenone: a radiosensitizer for anoxic bacterial and mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 1.17
Effects of sensitizers on cell respiration: 1. Factors influencing the effects of hypoxic cell radiosensitizers on oxygen utilization of tumour and cultured mammalian cells. Br J Cancer Suppl (1978) 1.16
Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models. Mol Pharmacol (1977) 1.13
Effects of dimethyl sulfoxide and hypoxic cell radiosensitizers on the radiation response of the KHT murine tumor in vivo. Radiat Res (1977) 1.04
Hypoxic cells in an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 1.02
Letter: Modification of the radiation response of an in vitro tumour model by control of cellular respiration. Int J Radiat Biol Relat Stud Phys Chem Med (1974) 0.92
Radiosensitization of mammalian cells by p-nitroacetophenone. I. Characterization in asynchronous and synchronous populations. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 0.80
[Activity on Trichomonas vaginalis and other chemotherapeutic properties of 1-(2-hydroxyethyl)-2-carbamoyl-5-nitropyrrole (15,960 RP)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.79
Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res (1990) 4.60
Principles and applications of ultrasound backscatter microscopy. IEEE Trans Ultrason Ferroelectr Freq Control (1993) 2.98
Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res (1987) 2.85
Radiation response of multicell spheroids--an in vitro tumour model. Curr Top Radiat Res Q (1976) 2.73
An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiat Res (1974) 2.62
Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med (1976) 2.56
Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology (1977) 2.55
Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. Cancer Res (1976) 2.26
Risk adjustment and Medicare: taking a closer look. Health Aff (Millwood) (1997) 2.08
Presence of nucleoside triphosphate phosphohydrolase activity in purified virions of reovirus. J Virol (1970) 2.04
New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin. J Virol (1973) 1.99
Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer (1995) 1.96
Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn (2001) 1.93
Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells. Radiology (1975) 1.90
Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials. Br J Radiol (1974) 1.87
In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique. Br J Radiol (1975) 1.86
Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol (1998) 1.85
A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer (1981) 1.85
Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys (1986) 1.84
Effects of intercellular contact on repair of radiation damage. Exp Cell Res (1972) 1.76
Use of Hoechst 33342 for cell selection from multicell systems. J Histochem Cytochem (1982) 1.72
The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int J Radiat Oncol Biol Phys (1989) 1.71
Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res (1983) 1.67
Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem (1998) 1.67
Chemical radioprotection and radiosensitization of mammalian cells growing in vitro. Radiat Res (1973) 1.66
Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J Nucl Med (1993) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Cell selection from a murine tumour using the fluorescent probe Hoechst 33342. Br J Cancer (1985) 1.57
Cytotoxicity, Mutagenicity and DNA damage by Hoechst 33342. J Histochem Cytochem (1982) 1.56
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res (2001) 1.55
Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to x rays. Br J Radiol (1973) 1.53
Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Br J Cancer (1985) 1.47
Evidence for dark-reactivation of ultraviolet light damage in mouse L cells. Radiat Res (1967) 1.47
Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology (1997) 1.45
Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys (1997) 1.45
The effects of nitrobenzene derivatives on oxygen utilization and radiation response of an in vitro tumor model. Radiat Res (1976) 1.45
Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev (1994) 1.42
Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl (1978) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J Gastroenterol Hepatol (1998) 1.40
The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radic Biol Med (1997) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys (1986) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp Cell Res (1992) 1.30
The Physical State of Viral Nucleic Acid and the Sensitivity of Viruses to Ultraviolet Light. Biophys J (1965) 1.29
Hypoxic sensitizers--implications for radiation therapy. N Engl J Med (1979) 1.29
The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole. Br J Radiol (1983) 1.29
Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. Cancer Res (1981) 1.29
Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol (1988) 1.28
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer (1995) 1.28
Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol (2000) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
The interaction of caffeine with ultra-violet-light-irradiated DNA. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 1.27
Letter: Hypoxic radiosensitizers and cellular respiration. Br J Radiol (1976) 1.27
Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers. Cancer Res (1993) 1.25
Coumarin-3-carboxylic acid as a detector for hydroxyl radicals generated chemically and by gamma radiation. Radiat Res (1997) 1.25
Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol (1998) 1.24
Flow cytometry studies of intracellular adriamycin in single cells in vitro. Cancer Res (1981) 1.22
A novel technique for measuring human tissue pO2 at the cellular level. Br J Cancer (1986) 1.21
Extraordinary effects of specific monovalent cations on activation of reovirus transcriptase by chymotrypsin in vitro. J Virol (1973) 1.20
Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom (2006) 1.20
Nitrofurans as radiosensitizers of hypoxic mammalian cells. Cancer Res (1972) 1.19
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Inhibition of gamma-ray-induced degradation of E. coli Bs-1 DNA by infection with T1, T2 and T4 bacteriophage. Nature (1968) 1.19
Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. Cancer Res (1978) 1.19
Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am J Physiol (1996) 1.19
A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer (1996) 1.19
Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res (1987) 1.18
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. Cancer (2000) 1.18
An experimental and analytical study of oxygen depletion in stirred cell suspensions. Radiat Res (1980) 1.18
Reovirus transcriptase activation in vitro: involvement of an endogenous uncoating activity in the second stage of the process. Intervirology (1974) 1.17
Effects of sensitizers on cell respiration: 1. Factors influencing the effects of hypoxic cell radiosensitizers on oxygen utilization of tumour and cultured mammalian cells. Br J Cancer Suppl (1978) 1.16
Testing of hypoxic cell radiosensitizers in vivo. Br J Cancer Suppl (1978) 1.16
DNA strand breaks, repair, and survival in x-irradiated mammalian cells. Proc Natl Acad Sci U S A (1976) 1.16
Nascent DNA synthesis in ultraviolet light-irradiated mouse L cells. Biochim Biophys Acta (1972) 1.15
Ultraviolet irradiation of mouse L cells: effects on DNA synthesis and progression through the cell cycle. Radiat Res (1968) 1.14
Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models. Mol Pharmacol (1977) 1.13
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Hypoxic regions exist in human prostate carcinoma. Urology (1999) 1.13
The detection and measurement of hypoxic cells in solid tumors. Cancer (1984) 1.12
Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res (1998) 1.12
Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg (2000) 1.12
Changes in tumor hypoxia measured with a double hypoxic marker technique. Int J Radiat Oncol Biol Phys (2000) 1.12
Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol (1999) 1.11
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys (2000) 1.11
Mechanism of copper-catalyzed autoxidation of cysteine. Free Radic Res (1999) 1.11
Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia. J Nucl Med (1991) 1.10
Effects of caffeine on ultraviolet-irradiated mouse L cells. Radiat Res (1969) 1.10
Variable radiobiological responses of spheroids. Radiat Res (1980) 1.10
Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment. J Natl Cancer Inst (1986) 1.10